Comment From Breakthrough Breast Cancer On Possible New Genetic evaluating Technique
Dr Sarah Rawlings, Head of Policy & Involvement at Breakthrough Breast Cancer, says: “Only around 5% of all breast cancer cases are due to inherited faults in known breast cancer genes such as BRCA1 and BRCA2. Genetic examining is currently only offered to women with a strong family history of the disease and is not relevant for the majority of women. “Women tell us that it can be distressing to wait for the results of a genetic pop quiz.
Original post by Women’s Health / Gynecology News From Medical News Today
Related Articles
Breakthrough Breast Cancer’s Comment On Genetic Tests For Breast Cancer Comment From Breakthrough Breast Cancer Re Today’s Breast Screening Story Comment From Breakthrough Breast Cancer Re Lapatanib (Tyveb) Offers Hope After Herceptin Has folded In Her2 Positive Advanced Breast Cancer Comment From Breakthrough Breast Cancer On Cochrane Review Of Breast Self Examination Breakthrough’s Comment On Research Presented At The European Breast Cancer Conference, Looking At Breast Screening For Women Aged Up To 75, UK
No comments yet. Be the first.
Leave a reply
